The Biological and Clinical Aspects of a Latent Tuberculosis Infection

por Khabibullina, Nelli F., Kutuzova, Daria M., Burmistrova, Irina A., Lyadova, Irina V.
Publicado 2022

Comparative Study of Nanoparticle Blood Circulation after Forced Clearance of Own Erythrocytes (Mononuclear Phagocyte System-Cytoblockade) or Administration of Cytotoxic Doxorubici...

por Mochalova, Elizaveta N., Egorova, Elena A., Komarova, Kristina S., Shipunova, Victoria O., Khabibullina, Nelli F., Nikitin, Petr I., Nikitin, Maxim P.
Publicado 2023

Mechanistic insights into the slow peptide bond formation with D-amino acids in the ribosomal active site

por Melnikov, Sergey V, Khabibullina, Nelli F, Mairhofer, Elisabeth, Vargas-Rodriguez, Oscar, Reynolds, Noah M, Micura, Ronald, Söll, Dieter, Polikanov, Yury S
Publicado 2019

Co-produced natural ketolides methymycin and pikromycin inhibit bacterial growth by preventing synthesis of a limited number of proteins

por Almutairi, Mashal M., Svetlov, Maxim S., Hansen, Douglas A., Khabibullina, Nelli F., Klepacki, Dorota, Kang, Han-Young, Sherman, David H., Vázquez-Laslop, Nora, Polikanov, Yury S., Mankin, Alexander S.
Publicado 2017

Madumycin II inhibits peptide bond formation by forcing the peptidyl transferase center into an inactive state

por Osterman, Ilya A., Khabibullina, Nelli F., Komarova, Ekaterina S., Kasatsky, Pavel, Kartsev, Victor G., Bogdanov, Alexey A., Dontsova, Olga A., Konevega, Andrey L., Sergiev, Petr V., Polikanov, Yury S.
Publicado 2017

Structure of ribosome-bound azole-modified peptide phazolicin rationalizes its species-specific mode of bacterial translation inhibition

por Travin, Dmitrii Y., Watson, Zoe L., Metelev, Mikhail, Ward, Fred R., Osterman, Ilya A., Khven, Irina M., Khabibullina, Nelli F., Serebryakova, Marina, Mergaert, Peter, Polikanov, Yury S., Cate, Jamie H. D., Severinov, Konstantin
Publicado 2019

Effects of active cancer treatment on safety and immunogenicity of COVID-19 mRNA-BNT162b2 vaccine: preliminary results from the prospective observational Vax-On study

por Nelli, F., Fabbri, A., Onorato, A., Giannarelli, D., Silvestri, M.A., Giron Berrios, J.R., Virtuoso, A., Marrucci, E., Signorelli, C., Chilelli, M.G., Primi, F., Schirripa, M., Mazzotta, M., Ruggeri, E.M.
Publicado 2022

Klebsazolicin inhibits 70S ribosome by obstruction of the peptide exit tunnel

por Metelev, Mikhail, Osterman, Ilya A., Ghilarov, Dmitry, Khabibullina, Nelli F., Yakimov, Alexander, Shabalin, Konstantin, Utkina, Irina, Travin, Dmitry Y., Komarova, Ekaterina S., Serebryakova, Marina, Artamonova, Tatyana, Khodorkovskii, Mikhail, Konevega, Andrey L., Sergiev, Petr V., Severinov, Konstantin, Polikanov, Yury S.
Publicado 2017

Six month immunogenicity of COVID-19 mRNA-BNT162b2 vaccine in actively treated cancer patients: updated results of the Vax-On study

por Nelli, F., Fabbri, A., Onorato, A., Giannarelli, D., Silvestri, M.A., Pessina, G., Giron Berrios, J.R., Virtuoso, A., Marrucci, E., Schirripa, M., Mazzotta, M., Panichi, V., Cercola, P., Signorelli, C., Chilelli, M.G., Primi, F., Ruggeri, E.M.
Publicado 2022

Antineoplastic treatment class modulates COVID-19 mRNA-BNT162b2 vaccine immunogenicity in cancer patients: a secondary analysis of the prospective Vax-On study

por Ruggeri, E.M., Nelli, F., Fabbri, A., Onorato, A., Giannarelli, D., Giron Berrios, J.R., Virtuoso, A., Marrucci, E., Mazzotta, M., Schirripa, M., Panichi, V., Pessina, G., Signorelli, C., Chilelli, M.G., Primi, F., Natoni, F., Fazio, S., Silvestri, M.A.
Publicado 2021

Immunogenicity and early clinical outcome after two or three doses of SARS-CoV-2 mRNA-BNT162b2 vaccine in actively treated cancer patients: results from the prospective observation...

por Nelli, F., Giannarelli, D., Fabbri, A., Silvestri, M.A., Berrios, J. R. Giron, Virtuoso, A., Marrucci, E., Schirripa, M., Mazzotta, M., Onorato, A., Panichi, V., Topini, G., Pessina, G., Natoni, F., Signorelli, C., Chilelli, M.G., Primi, F., Ruggeri, E.M.
Publicado 2022